Eternity in Medical Information -- Medisurf
Items 81 ~ 72 of 279, Page 9 of 35
New 300mg Loading Dose Tablet For Plavix ®Receives Positive Opinion From The European Committee For Medicinal Products (CHMP)
A new step forward may help increase appropriate early use of Plavix
03.05.2008 Bristol-Myers Squibb (BMS)
Agreement With Abbott For Stem Cell Heart Failure Therapy, Mesoblast
02.19.2008 Australian Healthcare Association
Abbott Receives FDA Approval for SIMCOR ?(Niaspan ?/ simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
SIMCOR Is a New Single-Pill Combination of Two Proven Therapies that Significantly Raises HDL [Good] Cholesterol and Lowers LDL [Bad] Cholesterol
02.15.2008 Abbott Laboratories
Biotech buy
British drug company GlaxoSmithKline is to buy Reliant, a New Jersey biotechnology company that specializes in cardiovascular medicines, for US$1.65 b...
11.28.2007, Nature Publishing Group (NPG)
Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE (TM) V Drug Eluting Stent to FDA Advisory Committee on November 29
Data in Pre-Market Approval Application Are First Ever to Demonstrate Superiority of One Drug Eluting Stent Over Another in a Randomized Controlled Cl...
11.27.2007 Abbott Laboratories
Philips Unveils Computed Tomography (CT) System That Scans The Heart In Two Beats To Aid In Diagnosis And Treatment Of Serious Health Conditions, Royal Philips Electronics
11.26.2007 Australian Healthcare Association
Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE ® (Irbesartan-Hydrochlorothiazide)
the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood Pressure Goals
11.19.2007 Bristol-Myers Squibb (BMS)
CRESTOR (R) Now Indicated To Slow The Progression Of Atherosclerosis In Patients With Elevated Cholesterol
AstraZeneca announced today that the U.S. Food and Drug Administration (FDA) has approved CRESTOR (R) (rosuvastatin calcium) as an adjunct to diet to...
11.09.2007 AstraZeneca
1 2 3 4 5 6 7 8 9 10